Antibody Market Report – Research, Industry Analysis Reports and Market Demands

Global Antibody Market Growth 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Antibody Consumption Market Report

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Antibody Consumption 2014-2024
- 2.1.2 Antibody Consumption CAGR by Region
2.2 Antibody Segment by Type
- 2.2.1 IgM
- 2.2.2 IgG
- 2.2.3 IgA
- 2.2.4 Other
2.3 Antibody Consumption by Type
- 2.3.1 Global Antibody Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Antibody Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Antibody Sale Price by Type (2014-2019)
2.4 Antibody Segment by Application
- 2.4.1 Therapeutic
- 2.4.2 Research
- 2.4.3 Diagnostic
2.5 Antibody Consumption by Application
- 2.5.1 Global Antibody Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Antibody Value and Market Share by Application (2014-2019)
- 2.5.3 Global Antibody Sale Price by Application (2014-2019)

3 Global Antibody by Players

3.1 Global Antibody Sales Market Share by Players
- 3.1.1 Global Antibody Sales by Players (2017-2019)
- 3.1.2 Global Antibody Sales Market Share by Players (2017-2019)
3.2 Global Antibody Revenue Market Share by Players
- 3.2.1 Global Antibody Revenue by Players (2017-2019)
- 3.2.2 Global Antibody Revenue Market Share by Players (2017-2019)
3.3 Global Antibody Sale Price by Players
3.4 Global Antibody Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Antibody Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Antibody Products Offered
3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antibody by Regions

4.1 Antibody by Regions
- 4.1.1 Global Antibody Consumption by Regions
- 4.1.2 Global Antibody Value by Regions
4.2 Americas Antibody Consumption Growth
4.3 APAC Antibody Consumption Growth
4.4 Europe Antibody Consumption Growth
4.5 Middle East & Africa Antibody Consumption Growth

5 Americas

5.1 Americas Antibody Consumption by Countries
- 5.1.1 Americas Antibody Consumption by Countries (2014-2019)
- 5.1.2 Americas Antibody Value by Countries (2014-2019)
5.2 Americas Antibody Consumption by Type
5.3 Americas Antibody Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Antibody Consumption by Countries
- 6.1.1 APAC Antibody Consumption by Countries (2014-2019)
- 6.1.2 APAC Antibody Value by Countries (2014-2019)
6.2 APAC Antibody Consumption by Type
6.3 APAC Antibody Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Antibody by Countries
- 7.1.1 Europe Antibody Consumption by Countries (2014-2019)
- 7.1.2 Europe Antibody Value by Countries (2014-2019)
7.2 Europe Antibody Consumption by Type
7.3 Europe Antibody Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Antibody by Countries
- 8.1.1 Middle East & Africa Antibody Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Antibody Value by Countries (2014-2019)
8.2 Middle East & Africa Antibody Consumption by Type
8.3 Middle East & Africa Antibody Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
10.2 Antibody Distributors
10.3 Antibody Customer

11 Global Antibody Market Forecast

11.1 Global Antibody Consumption Forecast (2019-2024)
11.2 Global Antibody Forecast by Regions
- 11.2.1 Global Antibody Forecast by Regions (2019-2024)
- 11.2.2 Global Antibody Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
11.7 Global Antibody Forecast by Type
11.8 Global Antibody Forecast by Application

12 Key Players Analysis

13 Research Findings and Conclusion

Description

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China.
In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12%
In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016.
The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.

According to this study, over the next five years the Antibody market will register a 5.4% CAGR in terms of revenue, the global market size will reach US$ 9530 million by 2024, from US$ 7330 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antibody business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody market by product type, application, key manufacturers and key regions and countries.

This study considers the Antibody value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
IgM
IgG
IgA
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Therapeutic
Research
Diagnostic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Antibody consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antibody market by identifying its various subsegments.
Focuses on the key global Antibody manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antibody with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antibody submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.